Ceramides and mitochondrial fatty acid oxidation in obesity
- PMID: 28003342
- DOI: 10.1096/fj.201601156R
Ceramides and mitochondrial fatty acid oxidation in obesity
Abstract
Obesity is an epidemic, complex disease that is characterized by increased glucose, lipids, and low-grade inflammation in the circulation, among other factors. It creates the perfect scenario for the production of ceramide, the building block of the sphingolipid family of lipids, which is involved in metabolic disorders such as obesity, diabetes, and cardiovascular disease. In addition, obesity causes a decrease in fatty acid oxidation (FAO), which contributes to lipid accumulation within the cells, conferring more susceptibility to cell dysfunction. C16:0 ceramide, a specific ceramide species, has been identified recently as the principal mediator of obesity-derived insulin resistance, impaired fatty acid oxidation, and hepatic steatosis. In this review, we have sought to cover the importance of the ceramide species and their metabolism, the main ceramide signaling pathways in obesity, and the link between C16:0 ceramide, FAO, and obesity.-Fucho, R., Casals, N., Serra, D., Herrero, L. Ceramides and mitochondrial fatty acid oxidation in obesity.
Keywords: C16:0 ceramide; carnitine palmitoyltransferase 1; energy expenditure; insulin resistance.
© FASEB.
Similar articles
-
Fenofibrate Reverses Palmitate Induced Impairment in Glucose Uptake in Skeletal Muscle Cells by Preventing Cytosolic Ceramide Accumulation.Cell Physiol Biochem. 2015;37(4):1315-28. doi: 10.1159/000430399. Epub 2015 Oct 22. Cell Physiol Biochem. 2015. PMID: 26488284
-
Ceramides as modulators of cellular and whole-body metabolism.J Clin Invest. 2011 Nov;121(11):4222-30. doi: 10.1172/JCI57144. Epub 2011 Nov 1. J Clin Invest. 2011. PMID: 22045572 Free PMC article. Review.
-
Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes.Metabolism. 2018 May;82:118-123. doi: 10.1016/j.metabol.2017.12.012. Epub 2018 Jan 4. Metabolism. 2018. PMID: 29307520 Free PMC article.
-
Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis.Biochim Biophys Acta. 2015 Feb;1848(2):561-7. doi: 10.1016/j.bbamem.2014.11.018. Epub 2014 Nov 21. Biochim Biophys Acta. 2015. PMID: 25462172
-
Targeting ceramide metabolism in obesity.Am J Physiol Endocrinol Metab. 2016 Aug 1;311(2):E423-35. doi: 10.1152/ajpendo.00133.2016. Epub 2016 Jul 5. Am J Physiol Endocrinol Metab. 2016. PMID: 27382035 Review.
Cited by
-
Plasma Sphingomyelins and Carnitine Esters of Infants Consuming Whole Goat or Cow Milk-Based Infant Formulas or Human Milk.J Nutr. 2024 Jun;154(6):1781-1789. doi: 10.1016/j.tjnut.2024.04.020. Epub 2024 Apr 12. J Nutr. 2024. PMID: 38615734 Free PMC article. Clinical Trial.
-
Magnolia officinalis Rehder & E. Wilson ameliorates white adipogenesis by upregulating AMPK and SIRT1 in vitro and in vivo.Heliyon. 2024 Mar 7;10(6):e27600. doi: 10.1016/j.heliyon.2024.e27600. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38515723 Free PMC article.
-
The role of fatty acid metabolism in acute lung injury: a special focus on immunometabolism.Cell Mol Life Sci. 2024 Mar 8;81(1):120. doi: 10.1007/s00018-024-05131-4. Cell Mol Life Sci. 2024. PMID: 38456906 Free PMC article.
-
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.Respir Res. 2024 Jan 25;25(1):58. doi: 10.1186/s12931-023-02644-7. Respir Res. 2024. PMID: 38273290 Free PMC article.
-
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease.Nat Rev Nephrol. 2023 Oct;19(10):629-645. doi: 10.1038/s41581-023-00741-w. Epub 2023 Jul 27. Nat Rev Nephrol. 2023. PMID: 37500941 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical